Erol Veznedaroglu, MD, FACS, FAHA
Director
Neurosciences and Endovascular & Cerebrovascular Neurosurgery
Stroke & Cerebrovascular Center of New Jersey
Institute for Neurosciences
Capital Health
Trenton, NJ
Dr. Erol Veznedaroglu, also known as Dr. Vez, is director of Neurosciences and Endovascular & Cerebrovascular Neurosurgery at Capital Health. He was formerly director of the Division of Neurovascular Surgery and Endovascular Neurosurgery and director of the cerebrovascular fellowship program at Thomas Jefferson University Hospitals.
Following his fellowship training in cerebrovascular/neurointerventional neurosurgery and neuro-critical care at Thomas Jefferson University Hospital for Neuroscience, he became a nationally recognized endovascular and cerebrovascular neurosurgeon in the treatment of aneurysms, arteriovenous malformations, stroke and other potentially fatal conditions of the brain.
Since joining Capital Health two years ago, Dr. Veznedaroglu has spearheaded the development of the hospital’s neurosciences research program, the dedication of a 26-bed neurosurgical intensive care unit, and the opening of the country’s first and only dedicated neurologically focused emergency department.
Under his leadership, the neuroscience program at Capital Health became the first in the country to use TREVO, an investigation device for the removal of clots in ischemic stroke patients. The program was also the first in the Philadelphia region to use Solitaire, another investigational clot retrieval device.
Dr. Veznedaroglu has designed and invented coils for the treatment of wide-necked aneurysms. He was the first doctor in the mid-Atlantic region to use the wingspan stent system, the first FDA-approved stent used to open clogged arteries in the brain. He is also one of only a few physicians in the nation chosen by trial investigators to treat aneurysms with a "glue-like" substance called Onyx HD500. This substance is injected into an aneurysm where it quickly solidifies and cuts off the area's blood supply to prevent a potentially fatal burst.
Dr. Veznedaroglu was also the first in the region to use the Merci Retriever and Penumbra devices for the treatment of stroke, as well as the Cordis Enterprise Stent for the treatment of wide necked aneurysms. In addition to leading these and many other innovative best practices in stroke and cerebrovascular care, he is the only physician in the region who can proctor and train other physicians across the country on these same devices.
Dr. Veznedaroglu is the primary investigator of numerous clinical and basic science studies related to cerebrovascular disease. Dr. Veznedaroglu is a nationally recognized academic leader in the area of cerebrovascular care. He has written chapters and articles in various publications that are used as data for his colleagues across the country, and he is invited to lecture and chair at international conferences for physicians around the world.
For Non-Physicians
If you are not a physician and would like to contact the Center or schedule an appointment, please use this form.
For Physicians
If you would like to contact Dr. Veznedaroglu and/or set up an appointment to meet with him, please fill out the form below.
* indicates required field